Pharmaceutical News and Articles

Volume Rendering of Myocardium, Cardiac Valves Enables Visualization

which is essential for 4D moving images where there is simply too much information to process using traditional manual tracing methods, coauthor Matthew A. Joll

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

CAMBRIDGE, MASSACHUSETTS ACCESS Newswire February 18, 2026 Moderna, Inc. (NASDAQ MRNA) today announced that, in response to a prior Refusal-to-File (RTF) letter

FDA Approves Adquey (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis

Sandoz Receives US FDA Approval to Expand Enzeevu (aflibercept-abzv) Label for Multiple Retinal Indications

Ultra-Marathon Running Depletes Athletes' Red Blood Cells, Study Finds

THURSDAY, Feb. 19, 2026 Ultra-marathon runners must be incredibly fit to endure races that can extend more than 100 miles, but their bodies pay a price for thei

Drug-Resistant Salmonella Linked to Moringa Supplement

THURSDAY, Feb. 19, 2026 It s often touted as the miracle tree for its dense nutrient profile, but a popular moringa supplement is at the center of a superbug ou

Sweetened Drinks Linked to Higher Anxiety in Teens

THURSDAY, Feb. 19, 2026 While parents have long worried that too much sugar leads to cavities and weight gain, new research suggests that sugar rush might be fo

BJ’s Wholesale Club Issues Salmon Recall Across Seven East Coast States

THURSDAY, Feb. 19, 2026 If you recently bought frozen salmon at BJ s Wholesale Club, check the packaging before your next meal. Wellesley Farms Farm-Raised Atla

Firearm Injuries Tied to Long-Term Physical, Functional Health Challenges

Survivors of firearm injuries often experience long-term physical and functional health challenges, according to a study published online Jan. 26 in the Journal

Moderna’s mRNA Flu Vaccine Back Under FDA Review

THURSDAY, Feb. 19, 2026 In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna s experimental mRNA influenza vaccine. Th